Education
About Us
Working with TipRanks
Follow Us
MYND Life Sciences (TSE:MYND)
:MYND
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -332.99K | C$ -59.83K | C$ -86.12K | C$ 0.00 | C$ 0.00 |
| Operating Income | C$ -1.81M | C$ -3.06M | C$ -4.29M | C$ -56.47K | C$ -2.54K |
| EBITDA | C$ -1.83M | C$ -2.97M | C$ -4.21M | C$ 0.00 | C$ 0.00 |
| Net Income | C$ -1.52M | C$ -3.57M | C$ -4.37M | C$ -56.47K | C$ -2.54K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 257.00 | C$ 412.00 | C$ 1.90M | C$ 0.00 | C$ 0.00 |
| Total Assets | C$ 797.54K | C$ 654.12K | C$ 2.67M | C$ 70.00 | C$ 0.00 |
| Total Debt | C$ 3.00M | C$ 2.59M | C$ 2.32M | C$ 0.00 | C$ 0.00 |
| Net Debt | C$ 3.00M | C$ 2.59M | C$ 423.36K | C$ 0.00 | C$ 0.00 |
| Total Liabilities | C$ 5.77M | C$ 4.19M | C$ 2.74M | C$ 53.69K | C$ 1.83K |
| Stockholders' Equity | C$ -4.98M | C$ -3.53M | C$ -67.97K | C$ -53.62K | C$ -1.83K |
| Cash Flow | |||||
| Free Cash Flow | C$ -198.26K | C$ -1.82M | C$ -3.13M | C$ -2.78K | C$ -708.00 |
| Operating Cash Flow | C$ -198.26K | C$ -1.82M | C$ -2.98M | C$ -2.78K | C$ -708.00 |
| Investing Cash Flow | C$ 198.10K | C$ -80.00K | C$ 2.13M | C$ 0.00 | C$ 0.00 |
| Financing Cash Flow | C$ 0.00 | C$ 0.00 | C$ 2.75M | C$ 2.78K | C$ 708.00 |
MYND Life Sciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.